Cargando...

Durvalumab-induced myocarditis, myositis, and myasthenia gravis: a case report

BACKGROUND: Immune checkpoint inhibitors are effective therapies for a wide range of malignancies. Their increased use has led to a wide range of immune-related adverse effects including skin, gastrointestinal, pulmonary, endocrine, cardiac, and neurologic complications. CASE PRESENTATION: We presen...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Med Case Rep
Main Authors: Cham, Jason, Ng, Daniel, Nicholson, Laura
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8165972/
https://ncbi.nlm.nih.gov/pubmed/34053457
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13256-021-02858-7
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!